Late-onset hypogonadism

Piotr Dudek; Jarosław Kozakowski; Wojciech Zgliczyński

doi:10.5114/pm.2017.68595

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

2/2017
vol. 16

Send email

Copy url:

abstract:

Review paper

Late-onset hypogonadism

Piotr Dudek

,

Jarosław Kozakowski

,

Wojciech Zgliczyński

Menopause Rev 2017; 16(2): 66-69

DOI: https://doi.org/10.5114/pm.2017.68595

Online publish date: 2017/06/30

View full text Get citation

PlumX metrics:

In Poland, the number of men over the age of 50 years exceeds 6 million. It is estimated that about 2-6% of this population develops symptoms of late-onset hypogonadism (LOH). In men, testosterone deficiency increases slightly with age. LOH is a clinically and biochemically defined disease of older men with serum testosterone level below the reference parameters of younger healthy men and with symptoms of testosterone deficiency, manifested by pronounced disturbances of quality of life and harmful effects on multiple organ systems. Testosterone replacement therapy may give several benefits regarding body composition, metabolic control, and psychological and sexual parameters.

keywords:

Late-onset hypogonadism

Piotr Dudek , Jarosław Kozakowski , Wojciech Zgliczyński

the aging male, testosterone, late-onset hypogonadism

Piotr Dudek

,

Jarosław Kozakowski

,

Wojciech Zgliczyński